United States · FDA National Drug Code directory
Labetalol Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42806-329_b950655d-a9f8-4ace-bb56-0c7abbca231e
- Product NDC
- 42806-329
- Form
- TABLET
- Composition / generic term
- Labetalol Hydrochloride
- Labeler
- Epic Pharma, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210930
- Source listing expiry
- 20261231
Source-listed ingredients
- LABETALOL HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (42806-329-01) · 42806-329-01
- 500 TABLET in 1 BOTTLE (42806-329-05) · 42806-329-05
- 1000 TABLET in 1 BOTTLE (42806-329-10) · 42806-329-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →